Gait differences between COPD and healthy controls: systematic review and meta-analysis

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Buekers, Joren
  • dc.contributor.author Delgado Ortiz, Laura
  • dc.contributor.author Megaritis, Dimitrios
  • dc.contributor.author Polhemus, Ashley Marie
  • dc.contributor.author Breuls, Sofie
  • dc.contributor.author Buttery, Sara C.
  • dc.contributor.author Chynkiamis, Nikolaos
  • dc.contributor.author Demeyer, Heleen
  • dc.contributor.author Gimeno Santos, Elena, 1980-
  • dc.contributor.author Hume, Emily
  • dc.contributor.author Koch, Sarah
  • dc.contributor.author Williams, Parris
  • dc.contributor.author Wuyts, Marieke
  • dc.contributor.author Hopkinson, Nicholas S.
  • dc.contributor.author Vogiatzis, Ioannis
  • dc.contributor.author Troosters, Thierry
  • dc.contributor.author Frei, Anja
  • dc.contributor.author García Aymerich, Judith
  • dc.date.accessioned 2024-06-11T06:13:36Z
  • dc.date.available 2024-06-11T06:13:36Z
  • dc.date.issued 2024
  • dc.description.abstract Background: Despite the importance of gait as a determinant of falls, disability and mortality in older people, understanding of gait impairment in COPD is limited. This study aimed to identify differences in gait characteristics during supervised walking tests between people with COPD and healthy controls. Methods: We searched 11 electronic databases, supplemented by Google Scholar searches and manual collation of references, in November 2019 and updated the search in July 2021. Record screening and information extraction were performed independently by one reviewer and checked for accuracy by a second. Meta-analyses were performed in studies not considered at a high risk of bias. Results: Searches yielded 21 085 unique records, of which 25 were included in the systematic review (including 1015 people with COPD and 2229 healthy controls). Gait speed was assessed in 17 studies (usual speed: 12; fast speed: three; both speeds: two), step length in nine, step duration in seven, cadence in six, and step width in five. Five studies were considered at a high risk of bias. Low-quality evidence indicated that people with COPD walk more slowly than healthy controls at their usual speed (mean difference (MD) -19 cm·s-1, 95% CI -28 to -11 cm·s-1) and at a fast speed (MD -30 cm·s-1, 95% CI -47 to -13 cm·s-1). Alterations in other gait characteristics were not statistically significant. Conclusion: Low-quality evidence shows that people with COPD walk more slowly than healthy controls, which could contribute to an increased falls risk. The evidence for alterations in spatial and temporal components of gait was inconclusive. Gait impairment appears to be an important but understudied area in COPD.
  • dc.description.sponsorship This work was supported by the Mobilise-D project that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement number 820820. This JU receives support from the European Union's Horizon 2020 research and innovation programme, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The Barcelona Institute for Global Health (ISGlobal) receives support from the Spanish Ministry of Science, Innovation and Universities through the “Centro de Excelencia Severo Ochoa 2019–2023” programme (CEX 2018-000806-S), and support from the Generalitat de Catalunya through the CERCA programme. The views expressed are those of the authors and not necessarily those of the IMI, the European Union, the EFPIA or any associated partners. L. Delgado-Ortiz receives funding from the grant “Contratos Predoctorales de Formación en Investigación en Salud (PFIS) 2021 of the AES with Exp. FI21/00113” from ISCIII, and the European Social Fund Plus (ESF+). Funding information for this article has been deposited with the Crossref Funder Registry.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Buekers J, Delgado-Ortiz L, Megaritis D, Polhemus A, Breuls S, Buttery SC, et al. Gait differences between COPD and healthy controls: systematic review and meta-analysis. Eur Respir Rev. 2024 Apr 24;33(172):230253. DOI: 10.1183/16000617.0253-2023
  • dc.identifier.doi http://dx.doi.org/10.1183/16000617.0253-2023
  • dc.identifier.issn 0905-9180
  • dc.identifier.uri http://hdl.handle.net/10230/60424
  • dc.language.iso eng
  • dc.publisher European Respiratory Society
  • dc.relation.ispartof Eur Respir Rev. 2024 Apr 24;33(172):230253
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/820820
  • dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/CEX2018-000806-S
  • dc.rights © The authors 2024. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/). For commercial reproduction rights and permissions contact permissions@ersnet.org
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
  • dc.subject.other Pulmons--Malalties obstructives
  • dc.title Gait differences between COPD and healthy controls: systematic review and meta-analysis
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Departament de Medicina i Ciències de la Vida)
Articles (Barcelona Institute for Global Health (ISGlobal) – Campus Mar)
Documents OpenAIRE (Open Access Infrastructure for Research in Europe)